HCPLive Network

New Agent Significantly Improves Progression-Free Survival in Patients With Advanced ER+ Breast Cancer

Combining the investigational PD 0332991 with letrozole as first-line therapy extended progression-free survival in women with advanced estrogen-receptor positive breast cancer.

Click here to view this article.


Further Reading
When a patient gets bitten by a dog, there can be many issues doctors need to confront as treatment begins. Two doctors shared their experiences of a patient who was bitten by a dog and still had symptoms including swelling and pain 2 weeks after his K-9 encounter.
A new multi-step skin testing protocol effectively determines the presence of isosulfan blue allergy, according to a study conducted by researchers at the University of Virginia.
Using the metric of time to first cigarette after waking was found to help improve efficiency and reduce false-positive detection in lung cancer screening, a new case-control study suggests.
Among couples with an HIV-positive member, a study in the Cochrane Database of Systematic Reviews deemed antiretroviral therapy effective at preventing HIV transmission to the HIV-negative partner.
Widely known to prevent signs of aging, injections of Botox (onabotulinumtoxinA) could also be used to sever nerves to halt tumor growth in gastrointestinal cancer
For patients with advanced laryngeal cancer, there is a small but significant survival advantage with surgical treatment versus laryngeal conservation, according to a study published online Aug. 21 in JAMA Otolaryngology-Head & Neck Surgery.
Active surveillance for clinical stage I testis cancer leads to excellent outcomes, according to a study published online Aug. 18 in the Journal of Clinical Oncology.
More Reading